201 related articles for article (PubMed ID: 12579344)
1. SNPs and haplotypes: genetic markers for disease and drug response (review).
Shastry BS
Int J Mol Med; 2003 Mar; 11(3):379-82. PubMed ID: 12579344
[TBL] [Abstract][Full Text] [Related]
2. Single-nucleotide polymorphisms, haplotypes, and their relevance to pharmacogenetics.
Stephens JC
Mol Diagn; 1999 Dec; 4(4):309-17. PubMed ID: 10671641
[TBL] [Abstract][Full Text] [Related]
3. The use of single-nucleotide polymorphism maps in pharmacogenomics.
McCarthy JJ; Hilfiker R
Nat Biotechnol; 2000 May; 18(5):505-8. PubMed ID: 10802616
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers.
Grossman I; Avidan N; Singer C; Goldstaub D; Hayardeny L; Eyal E; Ben-Asher E; Paperna T; Pe'er I; Lancet D; Beckmann JS; Miller A
Pharmacogenet Genomics; 2007 Aug; 17(8):657-66. PubMed ID: 17622942
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics and genotyping: on the trail of SNPs.
Melton L
Nature; 2003 Apr; 422(6934):917, 919, 921, 923. PubMed ID: 12712209
[No Abstract] [Full Text] [Related]
7. Mapping a role for SNPs in drug development.
Rothberg BE
Nat Biotechnol; 2001 Mar; 19(3):209-11. PubMed ID: 11231544
[No Abstract] [Full Text] [Related]
8. Effects of single SNPs, haplotypes, and whole-genome LD maps on accuracy of association mapping.
Maniatis N; Collins A; Morton NE
Genet Epidemiol; 2007 Apr; 31(3):179-88. PubMed ID: 17285621
[TBL] [Abstract][Full Text] [Related]
9. Haplotype tagging in pharmacogenetics.
Goldstein DB
Novartis Found Symp; 2005; 267():14-9; discussion 19-30. PubMed ID: 15999798
[TBL] [Abstract][Full Text] [Related]
10. Introduction to SNPs: discovery of markers for disease.
Weiner MP; Hudson TJ
Biotechniques; 2002 Jun; Suppl():4-7, 10, 12-3. PubMed ID: 12083396
[No Abstract] [Full Text] [Related]
11. Advances in the development of genetic markers for the diagnosis of disease and drug response.
Halapi E; Hakonarson H
Expert Rev Mol Diagn; 2002 Sep; 2(5):411-21. PubMed ID: 12271813
[TBL] [Abstract][Full Text] [Related]
12. Population genetic tools: application to cancer.
Gabriel S
Semin Oncol; 2007 Apr; 34(2 Suppl 1):S21-4. PubMed ID: 17449348
[TBL] [Abstract][Full Text] [Related]
13. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
Smart A; Martin P
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
[TBL] [Abstract][Full Text] [Related]
14. Issues with polymorphism analysis in sepsis.
Sutherland AM; Russell JA
Clin Infect Dis; 2005 Nov; 41 Suppl 7():S396-402. PubMed ID: 16237637
[TBL] [Abstract][Full Text] [Related]
15. The challenge of using SNPs in the understanding and treatment of disease.
Schifreen RS; Storts DR; Buller AM
Biotechniques; 2002 Jun; Suppl():14-6, 18, 20-1. PubMed ID: 12083392
[No Abstract] [Full Text] [Related]
16. [Pharmacogenetical aspects of clinical anaesthesiology].
Burlev AV; Shifman EM
Anesteziol Reanimatol; 2010; (6):83-6. PubMed ID: 21400801
[TBL] [Abstract][Full Text] [Related]
17. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
18. The International HapMap Project.
International HapMap Consortium
Nature; 2003 Dec; 426(6968):789-96. PubMed ID: 14685227
[TBL] [Abstract][Full Text] [Related]
19. Risk assessment and pharmacogenetics in molecular and genomic epidemiology.
Park SK; Choi JY
J Prev Med Public Health; 2009 Nov; 42(6):371-6. PubMed ID: 20009483
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of disease-modifying anti-rheumatic drugs.
Tanaka E; Taniguchi A; Urano W; Yamanaka H; Kamatani N
Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):233-47. PubMed ID: 15121042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
